Steven C. Schallhorn.
​
JENA, Germany and DUBLIN, Calif.—Carl Zeiss Meditec has appointed Steven C. Schallhorn, MD as chief medical officer for global ophthalmic devices consisting of refractive lasers, surgical ophthalmology and ophthalmic diagnostics.

As the leading medical advisor for the organization, Dr. Schallhorn will serve on the executive leadership team providing strategic direction for the business and medical guidance on the clinical use of Zeiss’ broad portfolio of ophthalmic diagnostic and surgical technologies. He will collaborate with key opinion leaders and academic institutions on research initiatives and the development of best practices for improving clinical outcomes, practice efficiency and cost effectiveness, the company said.

“Dr. Schallhorn’s medical expertise is pivotal to our clinical and medical affairs strategy and our partnership with doctors, clinical advisors, academia, and ophthalmic associations,” said Jim Mazzo, global president ophthalmic devices. “Dr. Schallhorn’s advisory will be essential for the continued advancement of our innovations in the most relevant clinical way for excellent performance and practice efficiency.”

Dr. Schallhorn has led many clinical studies focused on the safety and effectiveness of eye surgery as well as the quality of vision. He has presented to the U.S. FDA numerous times and was instrumental in the approval of many ophthalmic devices and the NASA approval of LASIK.

Dr. Schallhorn is a board certified, licensed ophthalmologist in private practice in San Diego, Calif., a clinical professor of ophthalmology at the University of California, San Francisco and the chief medical director for Optical Express.